Martin M. Okun

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Alan Menter, Stephen K. Tyring, Kenneth B. Gordon et al. · Journal of the American Academy of Dermatology · 2007 · 869 citations

Autoimmune Disease, Systemic Treatment, Severe Psoriasis +7

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball, Martin M. Okun, David Williams et al. · New England Journal of Medicine · 2016 · 741 citations

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

Kenneth B. Gordon, Richard G. Langley, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology · 2006 · 502 citations

Open-label Extension Study, Systemic Treatment, Severe Psoriasis +6

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Alexa B. Kimball, Francisco A. Kerdel, David R. Adams et al. · Annals of Internal Medicine · 2012 · 406 citations

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

Richard Shikiar, Mary Kaye Willian, Martin M. Okun et al. · Health and Quality of Life Outcomes · 2006 · 208 citations · Full text